・STAgora™ analysis of approximately 60,000 test results collected over 42 months showed that STI pathogens were detected in 82% of HPV-positive cases
・Findings support the potential value of a comprehensive testing approach that provides both HPV and STI pathogen information
・Seegene to validate the clinical utility of comprehensive HPV & STI testing through the Global Million Clinical Study and establish scientific evidence for new global standards of PCR testing SEOUL, South Korea, July 27, 2026 /PRNewswire/ -- Seegene Inc., a global molecular diagnostics company, announced a compreh…READ FULL ARTICLE